Search Results 321-330 of 17539 for what is vedolizumab

1. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

   ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

2. A Study to Identify Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease - Mayo Clinic

   A Study to Identify Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic locations.

3. ROC curve for genetic, clinical, and genetic and clinical risk factors for early surgery in Crohn's disease - Mayo Clinic

   ... . IMG-20203731. Home; ROC curve for genetic, clinical, and genetic and clinical risk factors for early surgery in Crohn's disease ...

4. Novel stem cell therapy for perianal fistula in pediatric patients with Crohn's disease - Mayo Clinic

   Pediatric onset of Crohn's disease is associated with more-aggressive perianal fistula development. New therapy derives stem cells from patients' fat cells ...

5. Risankizumab-rzaa (injection route) - Side effects & dosage - Mayo Clinic

   Risankuzumab-rzaa injection is also used to treat moderate to severe active Crohn's disease and moderate to severe active ulcerative colitis. This medicine ...

6. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   Evidence now suggests that the most effective therapy early in the course of Crohn's disease (CD) and ulcerative colitis (UC) involves the use of immune ...

7. A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn’s Disease (CD) - Mayo Clinic

   A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn's Disease (CD) · Overview · Participation eligibility.

8. Ustekinumab-srlf (intravenous route, subcutaneous route) - Mayo Clinic

   Ustekinumab-srlf injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

9. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... vedolizumab at a dose approved for the treatment of UC, and has a documented history of failure to respond to or tolerate such treatment; OR has not had ...

10. IBD Pride Clinic: Belonging while battling bowel disease

    Dealing with chronic conditions like Crohn's disease and ulcerative colitis can be challenging and sometimes embarrassing. Inflammatory bowel disease (IBD) ...